When it comes to diabetes, women are at a distinct disadvantage

Article

Women with type 2 diabetes mellitus are far more likely to die from coronary heart disease than men with diabetes, according to a meta-analysis of 37 prospective cohort studies. In fact, after excluding eight studies that adjusted only for age, the pooled ratio of the relative risks for women compared with men was 1.46 (1.14?1.88).

Women with type 2 diabetes mellitus are far more likely to die from coronary heart disease than men with diabetes, according to a meta-analysis of 37 prospective cohort studies. In fact, after excluding eight studies that adjusted only for age, the pooled ratio of the relative risks for women compared with men was 1.46 (1.14–1.88).

Researchers from Australia also calculated the rate of fatal coronary heart disease to be more than three times higher in people with type 2 diabetes than in those without (5.4% vs. 1.6%, respectively).

It's still unknown whether the disparity between the sexes is because women have more adverse cardiovascular risk profiles at the outset, whether diabetes induces a more unfavorable cardiovascular risk profile in women, whether women are treated less aggressively than men, or because of some other reason.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.